Resilient biomedical scientists experienced setbacks during the pandemic

When COVID-19 presented the world with the greatest health challenge in modern history, it was biomedical scientists who stepped up to develop diagnostic testing and vaccines to slow the spread of the disease.

Eli Lilly and Innovent’s obesity drug mazdutide achieves positive Phase III results

Share this article The Phase III trials have shown a similar safety profile to previous trials of mazdutide. Credit: Pixel-Shot via Shutterstock. Innovent has reported

January 11, 2024

Largest genetic study of epilepsy finds new risk genes

The largest genetic study of its kind, coordinated by the International League Against Epilepsy, including scientists from FutureNeuro at RCSI University of Medicine and Health

August 31, 2023

mRNA therapy revives p53 to combat ovarian tumors

Ovarian cancer is often very aggressive and responds poorly to the therapies currently available. A recent study by Goethe University Frankfurt and University Hospital Frankfurt

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.